Severe allergic reactions involving a cytokine storm can follow vaccination for respiratory viruses such as influenza or COVID-19, writes Irene Mavrakakis, M.D., in the summer issue of the Journal of ...

As spring blooms in May, weed pollen peaks—triggering allergies for millions. Explore the science behind this reaction and ...

Class switching to IgE and affinity maturation of the antibodies occur in mucosal tissues, and this may limit the ability of IgE antibodies to mediate systemic anaphylaxis. Various mechanisms ...

Discover the causes, symptoms, and treatment of food allergies, and learn how to manage them safely with expert tips on ...

Investigating allergy prevention, this research highlights early intervention strategies and the promise of biologic ...

Biohaven Ltd. (NYSE:BHVN) has announced major breakthroughs with its novel precision immunology therapies, BHV-1400 and ...

Novartis’ anti-IgE antibody Xolair (omalizumab) has been a mainstay of treatment for refractory CSU for many years. However, the drug is heading for patent expiry in Europe this year and in the ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /EINPresswire.com/ -- The urticaria market size has surged from $4.03 billion in 2024 to $4.77 billion in 2025, achieving a substantial compound ...

Yet my experience is a blip among the millions of people with allergies in Australia. Around 5 million Australians live with ...

which are caused by immunoglobulin E antibodies’ reaction with food. This reaction leads to histamine or other allergic substances being released. IgE-mediated food allergies can be serious or ...

Drugmakers are turning to biomarkers, like folate receptor alpha, and even cell therapies to tackle this deadly cancer in new ...

A phase 1 study of the OX40 agonist BGB-A445, with or without tislelizumab, an anti-PD-1 monoclonal antibody, in patients with advanced NSCLC, HNSCC, or NPC.